The clinical stage of allergic rhinitis is correlated to inflammation as detected by nasal cytology

Inflammation and Allergy - Drug Targets

Volumn 10, Issue 6, 2011, Pages 472-476

  Gelardi, Matteo ^b   Incorvaia, Cristoforo ^a   Fiorella, Maria Luisa ^b   Petrone, Paolo ^b   Quaranta, Nicola ^b   Russo, Cosimo ^b   Puccinelli, Paola ^c   Dell'Albani, Ilaria ^c   Riario Sforza, Gian Galeazzo ^a   Cattaneo, Eleonora ^c   Passalacqua, Gianni ^d   Frati, Franco ^c   Boccardo, Rachele ^e   Bocciolini, Corso ^e   Caruso, Giuseppe ^e   Ciofalo, Andrea ^e   Dall'Olio, Danilo ^e   Landi, Massimo ^e   Maffezzoni, Enrico ^e   Poletti, Donatella ^e   Salerni, Lorenzo ^e   Tomaiuolo, Marilena ^e   Troiano, Leonardo ^e   more..

^a ICP Hospital   (Italy)

^b UNIVERSITY OF BARI   (Italy)

^c Medical and Scientific Department   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

^e NONE

Author keywords

Allergic rhinitis; Clinical severity; Eosinophils; Lymphocytes; Mast cells; Nasal cytology; Plasma cells

Indexed keywords

ADULT; ALLERGIC RHINITIS; ARTICLE; CYTOLOGY; DISEASE DURATION; DISEASE SEVERITY; EOSINOPHIL; FEMALE; GRASS POLLEN; HUMAN; INFLAMMATION; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MAST CELL; NEUTROPHIL; PLASMA CELL; SENSITIZATION; STAINING;

EID: 81155126241     PISSN: 18715281     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152811798104917     Document Type: Article

References (18)

1. Asher, M. I.; Montefort, S.; Biorksten, B.; Lai, C.K.; Strachan, D.P.; Weiland, S.K.; Williams, H. ISAAC Phase Three Study Group Allergies. Worldwide time trends in the prevalence of asthma, rhinoconjunctivitis, and eczema in childood: ISAAC Phase One and Three repeat multicountry cross-sectional surveys. Lancet, 2006, 368 (9537), 733-743.
2. Meltzer, E. P.; Blaiss, M. S.; Derebery, M. J.; Mahr, T. A.; Gordon, B.R.; Sheth, K. K.; Simons, A.L.; Wingertzahn, M.A.; Boyle, J.M. Burden of allergic rhinitis: results from the Pediatric Allergies in America surveys. J. Allergy Clin. Immunol., 2009, 124(3 Suppl): S43-70.
3. Ryan, D.; van Weel, C.; Bousquet, J.; Toskala, E.; Ahlstedt, S.; Palkonen, S.; van den Nieuwenhof, L.; Zuberbier, T.; Wickman, M.; Fokkens, W. Primary care: the cornerstone of diagnosis of allergic rhinitis. Allergy, 2008, 63(8), 981-989.
4. Bousquet, J.; van Cauweberge, P.; Khaltaev, N. ARIA Workshop Group; World Health Organization. Allergic Rhinitis and its Impact on Asthma. J. Allergy Clin. Immunol., 2001, 108 (5 Suppl): S147-334.
5. Carlsen, B.; Glenton C.; Pope, C. Thou shalt vs thou shalt not: a meta-synthesis of Gps attitudes to clinical practice guidelines. Br. J. Gen. Pract., 2007, 57(545), 971-978.
6. Meltzer, E. O.; Jalowayski, A. A. Nasal cytology in clinical practice. Am. J. Rhinol., 1988, 2, 47-54.
7. Bousquet, J.; Khaltaev, N.; Cruz, A. A., Eds. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 Update (in collaboration with the World Health Organization, GA2LEN and AllerGen). Allergy, 2008, 63(Suppl. 86): 8-160.
8. Van Hoecke, H.; Vastesaeger, N.; Dewulf, L.; Sys, L.; van Cauwenberge, P. Classification of allergic rhinitis patients in general practice during pollen season. Allergy, 2006, 61(6), 705-709.
9. Bousquet, J.; Schunemann, H. J.; Zuberbier, T.; Bachert, C.; Baena-Cagnani, C.; Bousquet, P. J.; Brozek, J.; Canonica, G.W.; Casale, T.B.; Demoly, P.; Gerth van Wijk, R.; Ohta, K.; Bateman, E.D.; Calderon, M.; Cruz, A.A.; Dolen, W.K.; Haughney, J.; Lockey, R.F.; Lötvall, J.; O'Byrne, P.; Spranger, O.; Togias, A.; Bonini, S.; Boulet, L.P.; Camargos, P.; Carlsen, K.H.; Chavannes, N.H.; Delgado, L.; Durham, S.R.; Fokkens, W.J.; Fonseca, J.; Haahtela, T.; Kalayci, O.; Kowalski, M.L.; Larenas-Linnemann, D.; Li, J.; Mohammad, Y.; Mullol, J.; Naclerio, R.; O'Hehir, R.E.; Papadopoulos, N.; Passalacqua, G.; Rabe, K.F.; Pawankar, R.; Ryan, D.; Samolinski, B.; Simons, F.E.; Valovirta, E.; Yorgancioglu, A.; Yusuf, O.M.; Agache, I.; Aït-Khaled, N.; Annesi-Maesano, I.; Beghe, B.; Ben Kheder, A.; Blaiss, M.S.; Boakye, D.A.; Bouchard, J.; Burney, P.G.; Busse, W.W.; Chan-Yeung, M.; Chen, Y.; Chuchalin, A.G.; Costa, D.J.; Custovic, A.; Dahl R.; Denburg, J.; Douagui, H.; Emuzyte, R.; Grouse, L.; Humbert, M.; Jackson, C.; Johnston, S.L.; Kaliner, M.A.; Keith, P.K.; Kim, Y.Y.; Klossek, J.M.; Kuna, P.; Le, L.T.; Lemiere, C.; Lipworth, B.; Mahboub, B.; Malo, J.L.; Marshall, G.D.; Mavale-Manuel, S.; Meltzer, E.O.; Morais-Almeida, M.; Motala, C.; Naspitz, C.; Nekam, K.; Niggemann, B.; Nizankowska-Mogilnicka, E.; Okamoto, Y.; Orru, M.P.; Ouedraogo, S.; Palkonen, S.; Popov, T.A.; Price, D.; Rosado-Pinto, J.; Scadding, G.K.; Sooronbaev, T.M.; Stoloff, S.W.; Toskala, E.; van Cauwenberge, P.; Vandenplas, O.; van Weel, C.; Viegi, G.; Virchow, J.C.; Wang, D.Y.; Wickman, M.; Williams, D.; Yawn, B.P.; Zar, H.J.; Zernotti, M.; Zhong, N. In collaboration with the WHO Collaborating Center of Asthma and Rhinitis (Montpellier). Development and implementation of guidelines in allergic rhinitis - an ARIA-GA2LEN paper. Allergy, 2010, 65 (10), 1212-1221.
10. Pastorello, E. A., Riario-Sforza G. G.; Incorvaia, C.; Segala, M.; Fumagalli, M.; Gandini, R. Comparison of rhinomanometry, symptom score, and inflammatory cells counts in assessing the nasal late-phase reaction to allergen challenge. J. Allergy Clin. Immunol., 1994, 93(1), 85-92.
11. Canonica G.W.; Compalati, E. Minimal persistent inflammation in allergic rhinitis: implications for current treatment strategies. Clin. Exp. Immunol., 2009, 158(3), 260-271.
12. Liu, F.; Zhang, J.; Liu, Y.; Zhang, N.; Holtappels, G.; Lin, P.; Liu, S.; Bachert, C. Inflammatory profiles in nasal mucosa of patients with persistent vs intermittent allergic rhinitis. Allergy, 2010, 65(9), 1149-1157.
13. Gelardi, M.; Fiorella M.L.; Russo, C.; Fiorella, R.; Ciprandi, G. Role of nasal cytology. Int. J. Immunopathol. Pharmacol., 2010, 23(1 suppl), 45-49.
14. Origlieri, C.; Bielory, L. Intranasal corticosteroids and allergic rhinoconjunctivitis. Curr. Opin. Allergy Clin. Immunol., 2008, 8(5), 450-456.
15. Cingi, C.; Kayabasoglu, G.; Nacar, A. Update on the medical treatment of allergic rhinitis. Inflamm. Allergy Drug Targets, 2009, 8(2), 96-103.
16. Senti, G.:, Martinez Gomez, J.M.; Rettig, L.; Wuthrich, B.; Kundig, T.M.; Johansen, P. Immunotherapeutic targeting of allergic diseases. Inflamm. Allergy Drug Targets, 2006, 5(4), 243-252.
17. Cox, L.; Nelson, H.; Lockey, R.; Calabria, C.; Chacko, T.; Finegold, I.; Nelson, M.; Weber, R.; Bernstein, D. I.; Blessing-Moore, J.; Khan, D. A.; Lang, D. M.; Nicklas, R. A.; Oppenheimer, J.; Portnoy, J. M.; Randolph, C.; Schuller, D. E.; Spector, S.L.; Tilles, S.; Wallace, D. Allergen immunotherapy: a practice parameter third update. J. Allergy Clin. Immunol., 2011, 127(Suppl 1), 1-55.
18. Incorvaia, C.; Masieri, S.; Berto, P.; Scurati, S.; Frati, F. Specific immunotherapy by the sublingual route for respiratory allergy. Allergy Asthma Clin. Immunol., 2010, 6(1), 29-32.